2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine

C46H84N14O24 — CID 91031451

IUPAC2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine
SMILESC[C@@H]1O[C@@H](OC2[C@@H](N=C(N)N)C(O)C(N=C(N)N)[C@H](O)[C@@H]2O)[C@@H](O[C@@H]2OC(CO)[C@H](O)C(O)[C@H]2N(C)CCCCN(C)C2[C@H](OC3[C@H](O[C@@H]4C(O)[C@@H](O)C(N=C(N)N)C(O)[C@@H]4N=C(N)N)O[C@@H](C)[C@@]3(O)C=O)OC(CO)[C@H](O)[C@@H]2O)C1(O)C=O
InChIInChI=1S/C46H84N14O24/c1-13-45(75,11-63)35(39(77-13)81-33-19(57-43(51)52)25(67)17(55-41(47)48)27(69)31(33)73)83-37-21(29(71)23(65)15(9-61)79-37)59(3)7-5-6-8-60(4)22-30(72)24(66)16(10-62)80-38(22)84-36-40(78-14(2)46(36,76)12-64)82-34-20(58-44(53)54)26(68)18(56-42(49)50)28(70)32(34)74/h11-40,61-62,65-76H,5-10H2,1-4H3,(H4,47,48,55)(H4,49,50,56)(H4,51,52,57)(H4,53,54,58)/t13-,14-,15?,16?,17?,18?,19-,20-,21+,22?,23-,24-,25?,26?,27-,28-,29?,30+,31-,32?,33?,34-,35+,36?,37-,38-,39-,40-,45?,46-/m0/s1
InChIKeyVZVHCUGRPLVARR-YVCAMEJFSA-N
MW1217.25 g/mol
LogP-15.10
Rot. Bonds23

About 2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine

2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine (PubChem CID 91031451) has the molecular formula C46H84N14O24 and a molecular weight of 1217.25 g/mol. Its IUPAC name is 2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine.

Molecular Properties

Compound Name2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine
PubChem CID91031451
Molecular FormulaC46H84N14O24
Molecular Weight1217.25 g/mol
Exact Mass1216.58
IUPAC Name2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine
SMILESC[C@@H]1O[C@@H](OC2[C@@H](N=C(N)N)C(O)C(N=C(N)N)[C@H](O)[C@@H]2O)[C@@H](O[C@@H]2OC(CO)[C@H](O)C(O)[C@H]2N(C)CCCCN(C)C2[C@H](OC3[C@H](O[C@@H]4C(O)[C@@H](O)C(N=C(N)N)C(O)[C@@H]4N=C(N)N)O[C@@H](C)[C@@]3(O)C=O)OC(CO)[C@H](O)[C@@H]2O)C1(O)C=O
InChIInChI=1S/C46H84N14O24/c1-13-45(75,11-63)35(39(77-13)81-33-19(57-43(51)52)25(67)17(55-41(47)48)27(69)31(33)73)83-37-21(29(71)23(65)15(9-61)79-37)59(3)7-5-6-8-60(4)22-30(72)24(66)16(10-62)80-38(22)84-36-40(78-14(2)46(36,76)12-64)82-34-20(58-44(53)54)26(68)18(56-42(49)50)28(70)32(34)74/h11-40,61-62,65-76H,5-10H2,1-4H3,(H4,47,48,55)(H4,49,50,56)(H4,51,52,57)(H4,53,54,58)/t13-,14-,15?,16?,17?,18?,19-,20-,21+,22?,23-,24-,25?,26?,27-,28-,29?,30+,31-,32?,33?,34-,35+,36?,37-,38-,39-,40-,45?,46-/m0/s1
InChIKeyVZVHCUGRPLVARR-YVCAMEJFSA-N
XLogP-15.10
TPSA655.28 Ų
H-Bond Donors22
H-Bond Acceptors30
Rotatable Bonds23
Heavy Atoms84
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001217.25
LogP ≤ 5-15.10
H-Bond Donors ≤ 522
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine?
The IUPAC name of 2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine (CID 91031451) is 2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine.
What is the SMILES notation for 2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine?
The canonical SMILES for 2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine is C[C@@H]1O[C@@H](OC2[C@@H](N=C(N)N)C(O)C(N=C(N)N)[C@H](O)[C@@H]2O)[C@@H](O[C@@H]2OC(CO)[C@H](O)C(O)[C@H]2N(C)CCCCN(C)C2[C@H](OC3[C@H](O[C@@H]4C(O)[C@@H](O)C(N=C(N)N)C(O)[C@@H]4N=C(N)N)O[C@@H](C)[C@@]3(O)C=O)OC(CO)[C@H](O)[C@@H]2O)C1(O)C=O.
What is the InChIKey of 2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine?
The InChIKey is VZVHCUGRPLVARR-YVCAMEJFSA-N. The full InChI is InChI=1S/C46H84N14O24/c1-13-45(75,11-63)35(39(77-13)81-33-19(57-43(51)52)25(67)17(55-41(47)48)27(69)31(33)73)83-37-21(29(71)23(65)15(9-61)79-37)59(3)7-5-6-8-60(4)22-30(72)24(66)16(10-62)80-38(22)84-36-40(78-14(2)46(36,76)12-64)82-34-20(58-44(53)54)26(68)18(56-42(49)50)28(70)32(34)74/h11-40,61-62,65-76H,5-10H2,1-4H3,(H4,47,48,55)(H4,49,50,56)(H4,51,52,57)(H4,53,54,58)/t13-,14-,15?,16?,17?,18?,19-,20-,21+,22?,23-,24-,25?,26?,27-,28-,29?,30+,31-,32?,33?,34-,35+,36?,37-,38-,39-,40-,45?,46-/m0/s1.
What are the key properties of 2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine?
2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine has a molecular weight of 1217.25 g/mol, XLogP of -15.10, 23 rotatable bonds, 22 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(1S,2S,4S)-2-[(2R,4S,5S)-3-[(2S,4R,5R)-3-[4-[[(2S,3R,5R)-2-[(2R,3S,5S)-2-[(2S,5S,6S)-2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-methylamino]butyl-methylamino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-5-(diaminomethylideneamino)-3,4,6-trihydroxycyclohexyl]guanidine is sourced from PubChem (CID 91031451), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).